These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 17395179

  • 1. Risperidone attenuates MK-801-induced hyperlocomotion in mice via the blockade of serotonin 5-HT 2A/2C receptors.
    Su YA, Si TM, Zhou DF, Guo CM, Wang XD, Yang Y, Shu L, Liang JH.
    Eur J Pharmacol; 2007 Jun 14; 564(1-3):123-30. PubMed ID: 17395179
    [Abstract] [Full Text] [Related]

  • 2. ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models.
    Gardell LR, Vanover KE, Pounds L, Johnson RW, Barido R, Anderson GT, Veinbergs I, Dyssegaard A, Brunmark P, Tabatabaei A, Davis RE, Brann MR, Hacksell U, Bonhaus DW.
    J Pharmacol Exp Ther; 2007 Aug 14; 322(2):862-70. PubMed ID: 17519387
    [Abstract] [Full Text] [Related]

  • 3. 5-HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice.
    Halberstadt AL, van der Heijden I, Ruderman MA, Risbrough VB, Gingrich JA, Geyer MA, Powell SB.
    Neuropsychopharmacology; 2009 Jul 14; 34(8):1958-67. PubMed ID: 19322172
    [Abstract] [Full Text] [Related]

  • 4. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P, Waters N, Schmidt CJ, Carlsson A, Carlsson ML.
    J Neural Transm (Vienna); 1998 Jul 14; 105(4-5):365-96. PubMed ID: 9720968
    [Abstract] [Full Text] [Related]

  • 5. The role of serotonin-2 (5-HT2) and dopamine receptors in the behavioral actions of the 5-HT2A/2C agonist, DOI, and putative 5-HT2C inverse agonist, SR46349B.
    Scarlota LC, Harvey JA, Aloyo VJ.
    Psychopharmacology (Berl); 2011 Feb 14; 213(2-3):393-401. PubMed ID: 20652541
    [Abstract] [Full Text] [Related]

  • 6. Attenuation of nicotine's discriminative stimulus effects in rats and its locomotor activity effects in mice by serotonergic 5-HT2A/2C receptor agonists.
    Batman AM, Munzar P, Beardsley PM.
    Psychopharmacology (Berl); 2005 May 14; 179(2):393-401. PubMed ID: 15565434
    [Abstract] [Full Text] [Related]

  • 7. A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.
    Canal CE, Morgan D, Felsing D, Kondabolu K, Rowland NE, Robertson KL, Sakhuja R, Booth RG.
    J Pharmacol Exp Ther; 2014 May 14; 349(2):310-8. PubMed ID: 24563531
    [Abstract] [Full Text] [Related]

  • 8. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
    Millan MJ, Mannoury la Cour C, Chanrion B, Dupuis DS, Di Cara B, Audinot V, Cussac D, Newman-Tancredi A, Kamal M, Boutin JA, Jockers R, Marin P, Bockaert J, Muller O, Dekeyne A, Lavielle G.
    J Pharmacol Exp Ther; 2012 Mar 14; 340(3):750-64. PubMed ID: 22178752
    [Abstract] [Full Text] [Related]

  • 9. MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.
    Martin P, Waters N, Waters S, Carlsson A, Carlsson ML.
    Eur J Pharmacol; 1997 Sep 24; 335(2-3):107-16. PubMed ID: 9369362
    [Abstract] [Full Text] [Related]

  • 10. Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice.
    Gleason SD, Shannon HE.
    Psychopharmacology (Berl); 1997 Jan 24; 129(1):79-84. PubMed ID: 9122367
    [Abstract] [Full Text] [Related]

  • 11. Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze.
    de Mello Cruz AP, Pinheiro G, Alves SH, Ferreira G, Mendes M, Faria L, Macedo CE, Motta V, Landeira-Fernandez J.
    Psychopharmacology (Berl); 2005 Nov 24; 182(3):345-54. PubMed ID: 16133141
    [Abstract] [Full Text] [Related]

  • 12. Serotonin 5-HT2A receptors underlie increased motor behaviors induced in dopamine-depleted rats by intrastriatal 5-HT2A/2C agonism.
    Bishop C, Tessmer JL, Ullrich T, Rice KC, Walker PD.
    J Pharmacol Exp Ther; 2004 Aug 24; 310(2):687-94. PubMed ID: 15044557
    [Abstract] [Full Text] [Related]

  • 13. 5-HT2A receptor antagonists block MK-801-induced stereotypy and hyperlocomotion.
    Ninan I, Kulkarni SK.
    Eur J Pharmacol; 1998 Oct 02; 358(2):111-6. PubMed ID: 9808259
    [Abstract] [Full Text] [Related]

  • 14. Advanced glycation end products elicit externalization of phosphatidylserine in a subpopulation of platelets via 5-HT2A/2C receptors.
    Wang Y, Beck W, Deppisch R, Marshall SM, Hoenich NA, Thompson MG.
    Am J Physiol Cell Physiol; 2007 Jul 02; 293(1):C328-36. PubMed ID: 17625040
    [Abstract] [Full Text] [Related]

  • 15. The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen.
    Canal CE, Olaghere da Silva UB, Gresch PJ, Watt EE, Sanders-Bush E, Airey DC.
    Psychopharmacology (Berl); 2010 Apr 02; 209(2):163-74. PubMed ID: 20165943
    [Abstract] [Full Text] [Related]

  • 16. M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats.
    Varty GB, Bakshi VP, Geyer MA.
    Neuropsychopharmacology; 1999 Apr 02; 20(4):311-21. PubMed ID: 10088132
    [Abstract] [Full Text] [Related]

  • 17. WAY-163909 [(7bR,10aR)-1,2,3,4,8,9,10,10a-octahydro-7bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A novel 5-hydroxytryptamine 2C receptor-selective agonist with preclinical antipsychotic-like activity.
    Marquis KL, Sabb AL, Logue SF, Brennan JA, Piesla MJ, Comery TA, Grauer SM, Ashby CR, Nguyen HQ, Dawson LA, Barrett JE, Stack G, Meltzer HY, Harrison BL, Rosenzweig-Lipson S.
    J Pharmacol Exp Ther; 2007 Jan 02; 320(1):486-96. PubMed ID: 17038512
    [Abstract] [Full Text] [Related]

  • 18. Effects of the serotonin 5-HT2A/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat.
    Monti JM, Jantos H.
    Eur J Pharmacol; 2006 Dec 28; 553(1-3):163-70. PubMed ID: 17059817
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL/6N mice.
    Dougherty JP, Aloyo VJ.
    Psychopharmacology (Berl); 2011 Jun 28; 215(3):581-93. PubMed ID: 21340474
    [Abstract] [Full Text] [Related]

  • 20. Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice.
    Gomes KS, Nunes-De-Souza RL.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct 01; 33(7):1261-9. PubMed ID: 19625008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.